HOME >> BIOLOGY >> NEWS
Data published in PNAS show antibodies can be made 10 times more toxic to cancer cells

Monrovia, CA March 7, 2006 Engineering the "Fc" region of monoclonal antibodies (mAbs) increases their toxicity to cancer cells, potentially improving the utility of targeted cancer therapies, according to research conducted at Xencor, which will be published in the March 14 print issue of the Proceedings of the National Academy of Sciences (PNAS).

Monoclonal antibodies have important advantages over chemotherapy and small molecule drug treatments for cancer, such as their specificity in targeting tumor cells and low toxicity. There are currently eight approved anticancer antibody products on the market today and many more are in development. Unfortunately, many marketed treatments lack the desired potency against tumor cells, providing only incremental improvements in therapeutic success, and many development-stage antibodies fail in clinical trials due to lack of demonstrated efficacy.

Scientists at Xencor, a biotherapeutics company developing protein and antibody therapeutics, said the changes it made to the antibody Fc regions increased antibody effector functions such as activation of immune cells for tumor lysis, called Antibody-Dependent Cell-mediated Cytotoxicity (ADCC), by more than two orders of magnitude. Studies conducted in in vivo models demonstrated that these antibodies were greater than ten times more toxic to target cells. The enhanced antibodies also were able to kill tumor cells that are typically "invisible" to other antibodies because they express low levels of target antigen.

"While antibodies such as Genentech's Rituxan are well known for their role in the treatment of cancer, many other promising antibodies are sub-optimal for use as therapeutics. They just aren't powerful enough," said Bassil Dahiyat, Ph.D., President and CEO of Xencor. "The work we published in PNAS shows that specific changes to the Fc regions of antibodies have the potential to greatly improve the effectiveness of next-ge
'"/>

Contact: Virginia Amann
vamann@pnlifesciences.com
608-274-6046
Porter Novelli, Life Sciences
6-Mar-2006


Page: 1 2

Related biology news :

1. Largest ever study of genetics of common diseases published today
2. Articles on animal migration published in BioScience
3. Home run study on spread of disease published
4. Authoritative new book on epigenetics published by CSHL Press
5. Genomic comparison of lactic acid bacteria published
6. Leeds Teaching Hospitals NHS Trust to host press conference call/webcast on data published in NEJM
7. The first tree genome is published: Poplar holds promise as renewable bioenergy resource
8. Combating anthrax: Results of study published this month as researchers look for a better vaccine
9. Tramiprosate (Alzhemed) preclinical results published in Neurobiology of Aging
10. FSU scientists biomolecular research published in Science, Nature
11. Turf management education resource published

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/27/2020)... , ... January 27, 2020 , ... On Thursday, February ... Solutions Life Sciences, Reed Tech and Richard Castle, Global Account Manager Medical ... discussing the procedure, other topics include EU MDR timing deadlines, best practices in creating ...
(Date:1/24/2020)... FARMINGTON, Conn. (PRWEB) , ... January 24, 2020 , ... ... populations down to the strain level, today announced that the company will debut a ... place January 26-29. , The new product, Shoreline Biome's Rapid Prep kit, is ...
(Date:1/24/2020)... ... January 24, 2020 , ... Worldwide Business with ... President Dr. Stanley Stanbridge and Vice President of Sales and Marketing Jeff Maier to ... Network as sponsored content on Sunday, Jan. 26, 2020 at 5:30 p.m. EST and ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... (PRWEB) , ... February 21, 2020 , ... ... to improve their manufacturing operations in order to adapt to new approaches like ... up with the increasing demand for personalized medicine and therapies. But with an ...
(Date:2/19/2020)... ... February 19, 2020 , ... Red Nucleus, a ... industry, today announced the opening of a new office in Tokyo, Japan. The ... , Red Nucleus announced the new office in response to customer requests for ...
(Date:2/11/2020)... (PRWEB) , ... February 11, 2020 , ... ... and residuals solutions services in North America, today announced that the City of ... solution to its biosolids management needs. Commencing in April of 2020, Synagro will ...
(Date:2/5/2020)... BEACH, Fla. (PRWEB) , ... February 05, 2020 , ... ... an annual observance, sponsored by The National Organization for Rare Disorders (NORD), to raise ... patients’ lives ( rarediseaseday.org ). The Balancing Act’s “Behind The Mystery” rare ...
Breaking Biology Technology:
Cached News: